SCHEMBL8528685

SCHEMBL8528685

O=C(CO)Oc1ccc2c(c1)C(=Cc1ccc3ccccc3c1)C(=O)N2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
PLK4 O00444 3/20 0.46
PLK1 P53350 2/20 0.46
LRRK2 Q5S007 2/20 0.45
RET P07949 4/20 0.45
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
TLK2 Q86UE8 1/20 0.44
PDGFRB P09619 2/20 0.43
EGFR P00533 1/20 0.43
KDR P35968 1/20 0.43
TPI1 P60174 1/20 0.43
PIM1 P11309 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8526464 0.81 KDM4E (0.56) KDM4EALDH1A1GAAMAPTPLK4
SCHEMBL8529701 0.80 KDM4E (0.47) KDM4EALDH1A1GAAMAPTPLK4
SCHEMBL8530176 0.80 KDM4E (0.52) KDM4EALDH1A1GAAMAPTPLK4
SCHEMBL5369374 0.79 TLK2 (0.71) RETTLK2PDGFRBKDRFLT3
SCHEMBL8587052 0.77 NTRK1 (0.60) KDM4EALDH1A1MAPTLRRK2RET
SCHEMBL8587050 0.77 NTRK1 (0.60) KDM4EALDH1A1MAPTLRRK2RET
SCHEMBL5474945 0.77 MAPT (0.68) KDM4EALDH1A1GAAMAPTPLK4
SCHEMBL5474941 0.77 MAPT (0.68) KDM4EALDH1A1GAAMAPTPLK4
SCHEMBL8529179 0.77 RAF1 (0.65) KDM4EALDH1A1GAAMAPTRET
SCHEMBL5472246 0.77 LRRK2 (0.73) KDM4EALDH1A1GAAMAPTLRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US claimed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP claimed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO claimed
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US disclosed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP disclosed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO disclosed